On January 10, 2026, Swissmedic issued an official recall notice regarding specific batches of Ringerfundin B. Braun Infusionslösung. This recall affects batch number 253527651, which must be withdrawn from the retail level due to quality concerns. Healthcare professionals, regulatory teams, and distributors are advised to take immediate action to ensure compliance and patient safety.
What changed?
Swissmedic identified a quality issue with batch 253527651 of Ringerfundin B. Braun Infusionslösung, mandating a recall. The product, distributed at retail levels, presents a potential risk, and corrective actions must be taken immediately to prevent further issues. Ringerfundin is commonly used as an isotonic solution for fluid replacement in medical contexts.
Who is affected?
This recall impacts health facilities, pharmacies, and distributors handling the affected batch. All clinical staff using or prescribing Ringerfundin B. Braun Infusionslösung should examine their supplies and remove any affected products. Additionally, patients and caregivers relying on the infusions solution should be notified through appropriate channels.
Recommendations and next steps
Swissmedic emphasizes the following steps:
- Check inventories for batch 253527651 of Ringerfundin B. Braun Infusionslösung.
- Quarantine and halt distribution or use of the affected batch.
- Notify relevant parties, including regulatory teams, quality assurance personnel, and healthcare facilities.
- Contact B. Braun or Swissmedic for detailed return instructions and updates.
Swissmedic has outlined detailed procedures for reporting adverse events and returning affected products. Compliance ensures both safety and adherence to regulatory protocols.
FAQ
Q1. Why was the batch recalled?
A1. The batch of Ringerfundin B. Braun Infusionslösung was recalled due to quality concerns found during routine checks, potentially compromising its safety or efficacy.
Q2. How can I identify the affected batch?
A2. Look for batch number 253527651 on the product labeling or packaging. Products from different batch numbers are not impacted.
Q3. What should distributors do?
A3. Distributors should immediately cease the sale of affected products, quarantine them, and coordinate with Swissmedic or B. Braun for further actions.
Conclusion
The recall of Ringerfundin B. Braun Infusionslösung batch 253527651 is a critical measure for ensuring patient safety and regulatory compliance. Healthcare and regulatory professionals must act swiftly to mitigate risks and remove the product from circulation.
Disclaimer
This article is for informational purposes only and does not constitute legal or medical advice. Professionals should rely on official notifications and consult directly with Swissmedic or the manufacturer for detailed instructions.
Swissmedic notice
For full information about the Swissmedic announcement, see the link below.